UBS Group AG - CORMEDIX INC ownership

CORMEDIX INC's ticker is CRMD and the CUSIP is 21900C100. A total of 30 filers reported holding CORMEDIX INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of CORMEDIX INC
ValueSharesWeighting
Q4 2018$1,0000.0%1,0000.0%0.00%
Q3 2018$1,0001,0000.0%0.00%
Q2 2018$0
-100.0%
1,000
-96.5%
0.00%
Q1 2018$5,000
-84.4%
28,700
-54.4%
0.00%
Q4 2017$32,000
+3100.0%
62,954
+4818.3%
0.00%
Q3 2017$1,000
-87.5%
1,280
-93.3%
0.00%
Q2 2017$8,000
-79.5%
19,194
-20.6%
0.00%
Q1 2017$39,0000.0%24,183
-4.4%
0.00%
Q4 2016$39,000
-54.1%
25,299
-24.6%
0.00%
Q3 2016$85,000
+34.9%
33,558
+5.1%
0.00%
Q2 2016$63,000
-24.1%
31,925
+2.1%
0.00%
Q1 2016$83,000
-66.9%
31,258
-74.8%
0.00%
Q4 2015$251,000
-23.7%
123,859
-25.1%
0.00%
Q3 2015$329,000
-59.3%
165,358
-20.5%
0.00%
-100.0%
Q2 2015$808,000
-57.4%
208,069
+8.0%
0.00%0.0%
Q1 2015$1,897,000192,7350.00%
Other shareholders
CORMEDIX INC shareholders Q1 2017
NameSharesValueWeighting ↓
Nine Chapters Capital Management LLC 42,400$22,0000.05%
SABBY MANAGEMENT, LLC 648,955$337,0000.02%
ELLIOTT MANAGEMENT CORP 4,166,868$2,167,0000.01%
Bollard Group LLC 401,920$209,0000.01%
RAY GERALD L & ASSOCIATES LTD 57,000$30,0000.00%
Virtu Financial LLC 100,138$52,0000.00%
Steward Partners Investment Advisory, LLC 48,590$25,0000.00%
Ahrens Investment Partners LLC 10,000$5,0000.00%
THOMPSON DAVIS & CO., INC. 2,000$1,0000.00%
TAURUS ASSET MANAGEMENT, LLC 30,000$16,0000.00%
View complete list of CORMEDIX INC shareholders